Latest Healthcare It News

Page 87 of 180
Vitura Health reported modest revenue growth but a robust 23.5% increase in EBITDA for FY2025, fueled by key acquisitions and expanding telehealth services. Despite margin pressures in medicinal cannabis, the company’s strategic reset under new leadership sets the stage for further growth.
Ada Torres
Ada Torres
25 Aug 2025
Apiam Animal Health has entered a Process Deed granting Adamantem exclusivity to pursue a $0.88 per share acquisition proposal. The Independent Board Committee signals intent to recommend the deal, pending due diligence and shareholder approval.
Ada Torres
Ada Torres
25 Aug 2025
Vitura Health reported a modest revenue increase to $124 million for FY2025, while net profit dipped 5.35% due to margin pressures and investment in new platforms. The company declared a fully franked dividend and highlighted growth in telehealth and medical services.
Ada Torres
Ada Torres
25 Aug 2025
Navigator Global Investments (NGI) reported a strong FY25 with record earnings driven by robust revenue growth and strategic investments, reinforcing its unique position in alternative asset management on the ASX.
Victor Sage
Victor Sage
25 Aug 2025
Navigator Global Investments has delivered a record financial performance in FY25, with Adjusted EBITDA rising 26% and net profit after tax soaring 80%, underpinned by strong asset growth and strategic board changes.
Claire Turing
Claire Turing
25 Aug 2025
Navigator Global Investments Limited (ASX, NGI) reported a robust 80% increase in net profit for FY25, driven by strong performance fees and strategic acquisitions including 1315 Capital Partners. The company also announced key board transitions as it reviews its dividend policy amid growth ambitions.
Claire Turing
Claire Turing
25 Aug 2025
PeopleIN’s FY2025 results reveal a revenue dip amid challenging conditions, offset by strategic cost savings, strong cash flow, and a $6 million share buy-back, positioning the company for growth in Queensland and Defence sectors.
Victor Sage
Victor Sage
25 Aug 2025
nib Holdings reported a solid FY25 with underlying operating profit of $239.2 million and 3.2% policyholder growth, driven by digital innovation and operational efficiencies. The Group’s strategic focus on core health insurance and adjacent services sets the stage for continued momentum into FY26.
Ada Torres
Ada Torres
25 Aug 2025
nib Group reported solid FY25 results with revenue growth to $3.6 billion and a 9.4% rise in net profit after tax, while maintaining its full-year dividend at 29 cents per share. The company’s Australian private health insurance business achieved record policyholder growth amid ongoing claims inflation and operational efficiencies.
Ada Torres
Ada Torres
25 Aug 2025
nib holdings limited reported a 9.4% increase in net profit after tax to $198.6 million for FY25, alongside a 7.8% rise in group revenue to $3.6 billion. Despite a dip in underlying operating profit, the company declared a fully franked final dividend, maintaining its full-year payout at 29 cents per share.
Ada Torres
Ada Torres
25 Aug 2025
Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.
Ada Torres
Ada Torres
25 Aug 2025
Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.
Ada Torres
Ada Torres
25 Aug 2025